Skip to main content
Tianda Pharmaceuticals Limited logo

Tianda Pharmaceuticals Limited — Investor Relations & Filings

Ticker · 455 HKEX Manufacturing
Open in API
Filings indexed 13 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country HK Hong Kong
Listing HKEX 455

About Tianda Pharmaceuticals Limited

https://www.tiandapharma.com

Tianda Pharmaceuticals Limited is a specialty pharmaceutical enterprise engaged in the research, development, manufacturing, and sale of pharmaceutical, biotechnology, and healthcare products. The company focuses significantly on the Traditional Chinese Medicine (TCM) industrial chain, encompassing the cultivation of Chinese medicinal herbs, the production of decoction pieces, and the development of finished Chinese medicine products. Tianda Pharmaceuticals integrates modern technology, including artificial intelligence, into its TCM operations to enhance the entire industrial chain. The company also provides Chinese medicine clinical services and maintains R&D and production bases in mainland China.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April, 2026
Regulatory Filings
2026-05-06 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025
Regulatory Filings
2026-04-29 English
Notification Letter and Request Form to Non-Registered Shareholders
Report Publication Announcement Classification · 90% confidence The document is a notification letter sent to non-registered shareholders informing them that the Company’s Annual Report 2025 and related circulars, AGM notice, and proxy form are available on its website and advising how to request printed copies. It does not contain the full report or financial data itself but merely announces the publication and provides instructions for access. This matches the definition of a Report Publication Announcement (RPA).
2026-04-29 English
Notification Letter and Reply Form to Registered Shareholders
Regulatory Filings
2026-04-29 English
Proxy form for use at the annual general meeting (the "AGM") of Tianda Pharmaceuticals Limited to be held on Friday, 12 June 2026 at 10:30 a.m. (or at any adjournment thereof)
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a proxy form used to appoint proxies and solicit votes ahead of the Annual General Meeting. It is part of the materials sent to shareholders to request votes on resolutions (e.g., re-election of directors, mandates). This aligns with the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-29 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 75% confidence The document is the formal Notice of Annual General Meeting for Tianda Pharmaceuticals Limited, outlining the date, venue, agenda items (including financial statements, director elections, share repurchase and issuance mandates), and proxy voting instructions. It is an AGM notice rather than an actual financial report or voting results. This falls under "AGM Information (Code: AGM-R)" which covers materials related to convening or supporting the Annual General Meeting.
2026-04-29 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.